Rare solitary metacarpophalangeal skeletal metastasis from poorly differentiated carcinoma of thyroid is reported in this communication. The case demonstrated excellent tumor marker and scan response to two fractions of radioiodine therapy (serum thyroglobulin 0.01 ng/ml at the time of the 3rd follow-up) and is being presently followed up on levothyroxine suppression.
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A 77-year-old-female initially presented with left thumb swelling [ Figure 1 ], which on fine-needle aspiration cytology was found to be metastatic follicular carcinoma of thyroid. X-ray left thumb demonstrated destructive lesion involving the proximal phalanx of thumb with disorganization of metacarpophalangeal joint with soft tissue [ Figure 2 ]. This was consistent with a metastatic deposit. The ultrasonography of the neck showed well-defined hypoechoic mass (3.7 cm × 2.9 cm × 2.2 cm in dimension) in the right lobe of thyroid with peripheral calcification. The patient underwent total thyroidectomy with right
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. The final histopathology turned out to be poorly differentiated carcinoma of the right lobe of thyroid, with reactive regional nodes and no extrathyroidal extension. The patient was subsequently treated twice with radioactive iodine ( 131 I), with excellent clinical, tumor marker, and scan response to administered therapy [ . The stimulated serum thyroglobulin (Tg) at the time of the 3 rd follow-up was 0.01 ng/ml with no abnormal focus in the scan. Apart from the rare site of metastasis from differentiated thyroid cancer, the case also illustrates the fact that small volume metastatic skeletal disease at times can demonstrate an excellent response to 131 I therapy. [1] [2] [3] [4] [5] 
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